DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Barrett-Lee P, Casbard A, Abraham J et al.
Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.
Lancet Oncol 2014;
15: 114-122
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.